1,367 results on '"Schoenfeld, David"'
Search Results
102. Comment on: Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors
103. PRE-MORBID TYPE 2 DIABETES MELLITUS AS A PROGNOSTIC FACTOR IN AMYOTROPHIC LATERAL SCLEROSIS
104. PRE-MORBID TYPE 2 DIABETES MELLITUS IS NOT A PROGNOSTIC FACTOR IN AMYOTROPHIC LATERAL SCLEROSIS
105. Assessment of Medical Student Milestones in Emergency Medicine Using Case-Based Simulation: 845
106. Acute effects of mecamylamine and varenicline on cognitive performance in non-smokers with and without schizophrenia
107. A Proportional Hazards Model for Truncated AIDS Data
108. Sample-Size Formula for the Proportional-Hazards Regression Model
109. Analysis of Multiple Tumor Data from a Rodent Carcinogenicity Experiment
110. Nomograms for Calculating the Number of Patients Needed for a Clinical Trial with Survival as an Endpoint
111. The Asymptotic Properties of Nonparametric Tests for Comparing Survival Distributions
112. Chi-Squared Goodness-of-Fit Tests for the Proportional Hazards Regression Model
113. A Modified Log Rank Test for Highly Stratified Data
114. Decreased Release of Gonadotropin-Releasing Hormone During the Preovulatory Midcycle Luteinizing Hormone Surge in Normal Women
115. Asymptotic Properties of Tests Based on Linear Combinations of the Orthogonal Components of the Cramer-Von Mises Statistic
116. Tests Based on Linear Combinations of the Orthogonal Components of the Cramer-von Mises Statistic When Parameters are Estimated
117. Confidence Bounds for Normal Means Under Order Restrictions, With Application to Dose-Response Curves, Toxicology Experiments, and Low-Dose Extrapolation
118. Statistical Issues Arising in AIDS Clinical Trials
119. [Information Seekers and Information Systems: A Policy Perspective]: Comment
120. Abstract 9899: Sex-Related Differences in Severe Cerebral Edema Development in Comatose Cardiac Arrest Patients
121. Effect of Esophageal Pressure–guided Positive End-Expiratory Pressure on Survival from Acute Respiratory Distress Syndrome: A Risk-based and Mechanistic Reanalysis of the EPVent-2 Trial
122. Sequential Therapy With Recombinant Human IGF ‐1 Followed by Risedronate Increases Spine Bone Mineral Density in Women With Anorexia Nervosa: A Randomized, Placebo‐Controlled Trial
123. Evaluation of Pharmacokinetics, Safety, Tolerance, and Activity of Combination of Zalcitabine and Zidovudine in Stable, Zidovudine-Treated Pediatric Patients with Human Immunodeficiency Virus Infection
124. The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis
125. Once-weekly d-cycloserine effects on negative symptoms and cognition in schizophrenia: An exploratory study
126. Driving Pressure and Survival in the Acute Respiratory Distress Syndrome
127. Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis
128. A Genomic Score Prognostic of Outcome in Trauma Patients
129. Long-term Outcome of a Cuffed Expanded PTFE Graft for Hemodialysis Vascular Access
130. Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19
131. Comparison of the Spo2/Fio2 Ratio and the Pao2/Fio2 Ratio in Patients With Acute Lung Injury or ARDS
132. Electrical impedance myography to assess outcome in amyotrophic lateral sclerosis clinical trials
133. Erratum to: Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial
134. A six-month, placebo-controlled trial of d-cycloserine co-administered with conventional antipsychotics in schizophrenia patients
135. Cell-specific expression and pathway analyses reveal alterations in trauma-related human T cell and monocyte pathways
136. Sequential Therapy With Recombinant Human IGF-1 Followed by Risedronate Increases Spine Bone Mineral Density in Women With Anorexia Nervosa
137. Effect of Transdermal Estradiol and Insulin-like Growth Factor-1 on Bone Endpoints of Young Women With Anorexia Nervosa
138. Increased cardiovascular disease risk indices in HIV-infected women
139. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents
140. Maintenance Treatment With Varenicline for Smoking Cessation in Patients With Schizophrenia and Bipolar Disorder: A Randomized Clinical Trial
141. Amyotrophic Lateral Sclerosis
142. Effects of GH on Body Composition and Cardiovascular Risk Markers in Young Men With Abdominal Obesity
143. Reply
144. Tryptophan depletion in SSRI-recovered depressed outpatients
145. PECAM-1 Affects GSK-3β-Mediated β-Catenin Phosphorylation and Degradation
146. DEVELOPING NORMALIZED STRENGTH SCORES FOR NEUROMUSCULAR RESEARCH
147. Comparison of analysis approaches for phase III clinical trials in amyotrophic lateral sclerosis
148. Coronary CT Angiography versus Standard Evaluation in Acute Chest Pain
149. VALIDATION OF A NEW STRENGTH MEASUREMENT DEVICE FOR AMYOTROPHIC LATERAL SCLEROSIS CLINICAL TRIALS†
150. Enabling a learning healthcare system with automated computer protocols that produce replicable and personalized clinician actions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.